Statistics from Altmetric.com
Dr Helen C Kales
Correspondence to: Dr Helen C Kales, MD, Department of Psychiatry, University of Michigan, Box 5765, 4250 Plymouth Road, Ann Arbor, MI 48109, USA; firstname.lastname@example.org
Is there a difference in mortality rate in the year after starting a new antipsychotic for neuropsychiatric symptoms of dementia and other psychiatric drugs?
10 615 older adults (over 65 years old) diagnosed with dementia in fiscal years 2002 or 2003 who started outpatient psychiatric medication within 6 months of being diagnosed with dementia. Exclusions: using psychiatric medication in 6 months prior to dementia diagnosis; receiving lithium; having a seizure disorder.
National Department of Veterans Affairs (VA) data registries, USA; fiscal years 2001–5.
Type of psychiatric medication: antipsychotic (conventional, atypical, or both) or other. Analyses were adjusted for potential confounders, including: age, gender, use of cholinesterase inhibitors, delirium diagnosis present at time of first prescription filling, date of starting psychiatric medication, schizophrenia or bipolar disorder diagnosis, days of hospitalisation in the …
Source of funding: VA Health Services Research and Career Development Award and VA grant.
▸Additional notes are published online only at http://ebmh.bmj.com/content/vol11/issue3
Competing interests: JW has received remuneration from Lilly and Janssen (makers of olanzapine and risperidone respectively) for educational activities..
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.